HALIFAX, NS, Aug. 17 /CNW/ - MedMira Inc., (“MedMira”) (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions, announced today that it has received product approval and the first order from its new Colombian agent, the IKXUR Company (IKXUR). MedMira will immediately ship 20,000 tests against a total order for 220,000 MiraWell(R) Rapid HIV Tests (MiraWell HIV). The balance of the order will be filled in quarterly shipments over the next year.
